课题基金 / 基金详情

2012 AAOS Femoroacetabular Impingement Research Symposium

2012 AAOS Femoroacetabular Impingement Research Symposium
2012 AAOS股骨髋臼撞击研究研讨会
批准号:
8201731
负责人:
JOHN C CLOHISY
金额:
$1.5万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2012-07-31

项目摘要

项目成果

JOHN C CLOHISY的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):骨性关节炎(OA)影响着大约30%的60岁以上的美国人,是骨科患者生活质量下降和功能丧失的主要原因之一。下肢骨关节炎尤其常见,且费用昂贵。据估计,到2030年,美国每年将进行超过440万例髋关节和膝关节置换手术,髋关节置换手术的数量将以200%的速度增长。需要创新的战略来更有效地诊断、预防和治疗骨性关节炎。未来的治疗创新将侧重于疾病的早期发现和治疗干预,以防止或阻止疾病的进展,并保护自然的髋关节。在过去的十年里,在阐明髋关节骨关节炎的病理生理学方面取得了重大进展。最重要的是,髋臼撞击(FAI)的深层病因作用已经走到了前列。FAI的特征是股骨近端和髋臼的结构畸形,沿着髋臼边缘产生异常的重复基台,导致负荷过大,髋臼边缘软骨损伤和进行性关节退变。FAI患者出现在不同年龄、不同疾病阶段。由于患者群体的多样性和疾病特征的多样性,FAI的治疗包括各种肌肉骨骼保健提供者,包括骨科外科医生(成人重建、儿科、运动和创伤)、风湿科医生、理疗师、物理治疗师和初级保健医生。尽管最近对FAI的外科治疗感兴趣并进行了技术创新,但在这一新兴领域仍有重大的基础和临床研究需要。此外,关于FAI在髋关节骨性关节炎中的病因学作用、FAI的自然历史、FAI的病理生理学、最佳诊断和疾病分期方式、不同治疗技术的有效性以及最合适的临床结果衡量标准和未来临床试验的最佳研究设计,仍存在重大争议。在这些问题上达成更好的共识将为未来的基础科学调查、临床试验和指导患者治疗的更好的临床证据提供基础。FAI的治疗进展取决于对疾病病理生理学的更好理解,以及确定不同治疗干预措施的临床疗效和经济价值。2012年AAOS髋臼撞击研究研讨会将强调多学科方法,并将重点总结当前的知识,就与FAI相关的几个关键问题达成共识并确定研究战略。重点主题包括:1)髋关节骨性关节炎的病因、流行病学和社会影响;2)FAI在髋关节骨性关节炎病理生理学中的作用;3)FAI的基础科学;4)FAI疾病筛查、诊断和疾病分期;5)不同治疗模式和最佳临床科学方法的相对有效性和结果;以及6)未来基础和临床研究的策略。 公共卫生相关性:据估计,60岁以上的美国人中有30%患有骨性关节炎,它是导致骨科患者生活质量下降和功能丧失的主要原因之一。下肢骨关节炎尤其常见,且费用昂贵。据估计,到2030年,美国每年将进行超过440万例髋关节和膝关节置换手术,髋关节置换手术的数量将增加200%。髋臼撞击(FAI)是髋关节骨性关节炎的潜在先兆。相对于髋关节骨关节炎,FAI的定义、诊断、治疗和病因学作用需要更好的共识。
英文摘要
DESCRIPTION (provided by applicant): Osteoarthritis (OA) affects an estimated 30% of Americans over 60 years of age and is one of the leading causes of reduced quality of life and loss of function for orthopaedic patients. Lower extremity OA is particularly common and costly. Estimates show that by 2030, over 4.4 million hip and knee replacement procedures will be performed annually in the United States with the number of hip replacements increasing by 200%. Innovative strategies are needed to more effectively diagnose, prevent and treat OA. Future treatment innovations will focus on early detection of disease and therapeutic interventions to prevent or halt disease progression and preserve the natural hip joint. Over the past decade there have been major advances in elucidating the pathophysiology of hip osteoarthritis. Most importantly, the profound etiological role of femoroacetabular impingement (FAI) has come to the forefront. FAI is characterized by structural deformities of the proximal femur and acetabulum that produce abnormal repetitive abutment along the acetabular rim resulting in excessive loading, acetabular rim cartilage damage and progressive joint degeneration. Patients with FAI present at various ages with diverse stages of disease. Due to the heterogeneous patient population and variability of disease characteristics, treatment of FAI encompasses a variety of musculoskeletal healthcare providers including orthopaedic surgeons (adult reconstruction, pediatrics, sports and trauma), rheumatologists, physiatrists, physical therapists and primary care physicians. Despite the recent interest and technical innovations for the surgical treatment of FAI, there is a major need for basic and clinical investigation in this burgeoning field. Additionally, significant controversy persists regarding the etiologic role of FAI in hip OA, the natural history of FAI, the pathophysiology of FAI, optimal diagnostic and disease staging modalities, the efficacy of different treatment techniques, and the most appropriate clinical outcome measures and optimal study designs for future clinical trials. Improved consensus regarding these issues will provide a foundation for future basic science investigations, clinical trials and improved clinical evidence to guide patient treatment. Advances in treating FAI are dependent upon improved understanding of the disease pathophysiology and determining the clinical efficacy and economic value of distinct treatment interventions. The 2012 AAOS Femoroacetabular Impingement research symposium will emphasize a multidisciplinary approach and will focus on summarizing current knowledge, developing consensus and identifying research strategies for several key issues related to FAI. Focus topics will include: 1) The etiology, epidemiology and societal impact of hip OA; 2) The role of FAI in hip OA pathophysiology; 3) The basic science of FAI; 4) FAI disease screening, diagnostics, and disease staging; 5) The relative effectiveness and outcomes of different treatment modalities and optimal clinical science methodologies; and 6) Strategies for future basic and clinical investigations. PUBLIC HEALTH RELEVANCE: Osteoarthritis (OA) affects an estimated 30% of Americans over 60 years of age and is one of the leading causes of reduced quality of life and loss of function for orthopaedic patients. Lower extremity OA is particularly common and costly. Estimates show that by 2030 over 4.4 million hip and knee replacement procedures will be performed annually in the United States with the number of hip replacements increasing by 200%. Femoroacetabular impingement (FAI) has recently come to the forefront as a potential precursor to hip osteoarthritis. There is a major need for improved consensus regarding the definition, diagnosis, treatment and etiological role of FAI relative to hip OA.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Femoroacetabular impingement research symposium.
股骨髋臼撞击研究研讨会。
DOI: 10.5435/jaaos-21-07-vi
发表时间: 2013
期刊: The Journal of the American Academy of Orthopaedic Surgeons
影响因子: --
作者: [Clohisy,JohnC, Kim,Young-Jo]
通讯作者: Kim,Young-Jo
MECHANISMS OF IMPLANT PARTICLE-INDUCED OSTEOCLASTOGENESI
  • 批准号:
    6375342
  • 项目类别:
  • 资助金额:
    $7.7万
  • 财政年份:
    2000
  • 负责人:
    JOHN C CLOHISY
  • 依托单位:
MECHANISMS OF IMPLANT PARTICLE-INDUCED OSTEOCLASTOGENESI
  • 批准号:
    6534507
  • 项目类别:
  • 资助金额:
    $7.7万
  • 财政年份:
    2000
  • 负责人:
    JOHN C CLOHISY
  • 依托单位:
MECHANISMS OF IMPLANT PARTICLE-INDUCED OSTEOCLASTOGENESI
  • 批准号:
    6188890
  • 项目类别:
  • 资助金额:
    $7.72万
  • 财政年份:
    2000
  • 负责人:
    JOHN C CLOHISY
  • 依托单位:
海外基金